Exploració per autor "Petrone, Paula"
Ara es mostren els items 1-8 de 8
-
Characteristic brain volumetric changes in the AD preclinical signature
Petrone, Paula; Casamitjana Díaz, Adrià; Falcón, Carlos; Artigues, Miquel; Operto, Grégory; Skouras, Stavros; Cacciaglia, Raffaele; Molinuevo, Jose Luis; Vilaplana Besler, Verónica; Gispert, Juan Domingo; Salvado, Gemma (Elsevier, 2018)
Article
Accés obert -
Magnetic resonance imaging and machine learning make a valuable combined tool for the screening of preclinical AD
Petrone, Paula; Vilaplana Besler, Verónica; Casamitjana Díaz, Adrià; Domingo Gispert, Juan; Molinuevo, Jose Luis; Sánchez Escobedo, Dalila (2017-07)
Article
Accés obert -
MRI-based screening of preclinical Alzheimer's disease for prevention clinical trials
Casamitjana Díaz, Adrià; Petrone, Paula; Tucholka, Alan; Falcón, Carlos; Skouras, Stavros; Molinuevo, José Luis; Vilaplana Besler, Verónica; Gispert, Juan Domingo (IOS Press, 2018)
Article
Accés obertThe identification of healthy individuals harboring amyloid pathology represents one important challenge for secondary prevention clinical trials in Alzheimer’s disease (AD). Consequently, noninvasive and cost-efficient ... -
Prediction of amyloid pathology in cognitively unimpaired individuals using voxel-wise analysis of longitudinal structural brain MRI
Petrone, Paula; Casamitjana Díaz, Adrià; Falcón, Carlos; Artigues, Miquel; Operto, Grégory; Cacciaglia, Raffaele; Molinuevo, José Luis; Vilaplana Besler, Verónica; Gispert, Juan Domingo (2019-08-17)
Article
Accés obertBackground Magnetic resonance imaging (MRI) has unveiled specific alterations at different stages of Alzheimer’s disease (AD) pathophysiologic continuum constituting what has been established as “AD signature”. To what ... -
Projection to latent spaces disentangles pathological effects on brain morphology in the asymptomatic phase of Alzheimer's disease
Casamitjana Díaz, Adrià; Petrone, Paula; Molinuevo, Jose Luis; Gispert, Juan Domingo; Vilaplana Besler, Verónica (2020-07-28)
Article
Accés obertAlzheimer's disease (AD) continuum is defined as a cascade of several neuropathological processes that can be measured using biomarkers, such as cerebrospinal fluid (CSF) levels of Aß, p-tau, and t-tau. In parallel, brain ... -
Projection to latent spaces disentangles specific cerebral morphometric patterns associated to aging and preclinical AD”,
Casamitjana Díaz, Adrià; Petrone, Paula; Artigues, Miquel; Molinuevo, Jose Luis; Gispert, Juan Domingo; Vilaplana Besler, Verónica (Elsevier, 2018)
Article
Accés obert -
Shared latent structures between imaging features and biomarkers in early stages of Alzheimer's disease
Casamitjana Díaz, Adrià; Vilaplana Besler, Verónica; Petrone, Paula; Molinuevo, Jose Luis; Gispert, Juan Domingo (Springer International Publishing, 2018)
Comunicació de congrés
Accés restringit per política de l'editorialIn this work, we identify meaningful latent patterns in MR images for patients across the Alzheimer’s disease (AD) continuum. For this purpose, we apply Projection to Latent Structures (PLS) method using cerebrospinal fluid ... -
Shared latent structures between imaging features and biomarkers in early stages of Alzheimer's disease: a predictive study
Casamitjana Díaz, Adrià; Petrone, Paula; Molinuevo, José Luis; Gispert, Juan Domingo; Vilaplana Besler, Verónica (2019-08-01)
Article
Accés obertMagnetic resonance imaging (MRI) provides high resolution brain morphological information and is used as a biomarker in neurodegenerative diseases. Population studies of brain morphology often seek to identify pathological ...